These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20418140)

  • 21. Improving pharmacy and therapeutics committee operations.
    Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE
    Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developing a unit-of-use drug distribution system for the hospital emergency room.
    Schiavone JD
    Hosp Pharm; 1981 Apr; 16(4):208-9, 214-5, 219 passim. PubMed ID: 10251101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involving physicians in efforts to control pharmaceutical expenditures.
    Shulkin DJ; McGourty ME; Bourret J
    Med Interface; 1995 Aug; 8(8):85-7, 90. PubMed ID: 10144777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Working together with medical service representatives.
    Oddis JA
    Resid Staff Physician; 1986 May; 32(5):16. PubMed ID: 10276980
    [No Abstract]   [Full Text] [Related]  

  • 25. A multidisciplinary process to determine, communicate, and manage an antibiotic formulary.
    Cook AA; Sanchez ML
    Hosp Pharm; 1992 Oct; 27(10):867-9, 872-4, 882. PubMed ID: 10121423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hospital restriction policy for newly marketed antimicrobial agents.
    Jeffrey LP; McCloskey WW; Rich DS; Mahoney CD
    Am J Hosp Pharm; 1986 Sep; 43(9):2230-2. PubMed ID: 3766580
    [No Abstract]   [Full Text] [Related]  

  • 27. [Management of the documentation and registries of the radiopharmacy units. General texts of the Royal Spanish Pharmacopeia with character of recommendation].
    Real Farmacopea Española
    Rev Esp Med Nucl; 2005; 24(6):424-8. PubMed ID: 16468167
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of pharmacy and therapeutics committee drug evaluation reports.
    Majercik PL; May JR; Longe RL; Johnson MH
    Am J Hosp Pharm; 1985 May; 42(5):1073-6. PubMed ID: 4003418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Drug committees: committees which will bring about a more conscious attitude to the choice of drugs].
    Hagelsten JO
    Sygeplejersken; 1978 Mar; 78(12):4-7, 20. PubMed ID: 254427
    [No Abstract]   [Full Text] [Related]  

  • 30. Key inventory to formulary to cut drug costs.
    Schmieding JL; Sita MJ
    Hospitals; 1980 Sep; 54(17):78-81. PubMed ID: 7399457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A medication use evaluation of alendronate: compliance with administration guidelines.
    Mersfelder T; Armitstead JA; Ivey MF; Cedars M
    Pharm Pract Manag Q; 1999 Jan; 18(4):50-8. PubMed ID: 10339068
    [No Abstract]   [Full Text] [Related]  

  • 32. Prescriber identification program.
    Frighetto L; Bunz D; Jewesson P
    Can J Hosp Pharm; 1991 Feb; 44(1):35-6. PubMed ID: 10110042
    [No Abstract]   [Full Text] [Related]  

  • 33. [Drug committees in Denmark. Status and future challenges].
    Rabøl R; Kampmann JP; Christensen HR
    Ugeskr Laeger; 2004 Aug; 166(35):2988-91. PubMed ID: 15387009
    [No Abstract]   [Full Text] [Related]  

  • 34. Legal issues associated with formulary product-selection when there are two or more recognized drug therapies.
    Liang FZ; Greenberg RB; Hogan GF
    Am J Hosp Pharm; 1988 Nov; 45(11):2372-5. PubMed ID: 3228094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hospital essential drugs in Africa. An example of pharmacoeconomic research].
    Meillon C; Stum N; Cuisinier-Raynal JC
    Dakar Med; 1996; Spec No():19-20. PubMed ID: 14520980
    [No Abstract]   [Full Text] [Related]  

  • 36. Off-label use reimbursement.
    Cohen J; Wilson A; Faden L
    Food Drug Law J; 2009; 64(2):391-403. PubMed ID: 19999289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementing and maintaining a viable formulary.
    Kelly WN; Bender FH
    Hosp Formul; 1983 Oct; 18(10):976-8, 981-2, 987. PubMed ID: 10262828
    [No Abstract]   [Full Text] [Related]  

  • 38. Procedure for evaluating nonformulary drug orders.
    Jay GT; Quercia RA; Gousse G; Chow MS; Quintiliani R
    Am J Hosp Pharm; 1993 Dec; 50(12):2554-6. PubMed ID: 8122692
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacy-managed patient-controlled analgesia service.
    McCall LJ; Dierks DR
    Am J Hosp Pharm; 1990 Dec; 47(12):2706-10. PubMed ID: 2278287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulary status of intravenous immunoglobulins in selected hospitals.
    Hatton RC; Doering PL; Fakhoury M; Williams RB
    Am J Hosp Pharm; 1988 Nov; 45(11):2377-9. PubMed ID: 3228096
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.